EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $867,000 | +5000.0% | 41,000 | +4000.0% | 0.05% | +2400.0% |
| Q1 2020 | $17,000 | -5.6% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | -14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $21,000 | -12.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $24,000 | +20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $20,000 | +11.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $18,000 | -18.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $22,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,000 | -26.7% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $30,000 | +25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $24,000 | -4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $25,000 | +13.6% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |